| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3192834 | Annals of Allergy, Asthma & Immunology | 2009 | 7 Pages |
Abstract
These results confirm that intranasal ciclesonide, 200 μg/d, has an onset of action of 6 hours in patients with SAR.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Peter MD, Sudeesha PhD, Nancy MS, Mark A. PhD,